Synthesis and Anticancer Activity of Novel Hydrazone Linkage-Based Aryl Sulfonate Derivatives as Apoptosis Inducers

dc.contributor.author Küçükgüzel, Şükriye Güniz
dc.contributor.author Han, M. Ihsan
dc.contributor.author Gurboga, Merve
dc.contributor.author Ozakpinar, Ozlem Bingol
dc.contributor.author Kucukguzel, S. Guniz
dc.contributor.other Eczacılık Meslek Bilimleri Bölümü
dc.date.accessioned 2025-01-11T13:00:32Z
dc.date.available 2025-01-11T13:00:32Z
dc.date.issued 2022
dc.description GURBOGA, MERVE/0000-0003-4614-7094; senkardes, sevil/0000-0002-0523-459X en_US
dc.description.abstract In the present study, the various 28 hybrid molecules containing hydrazone and sulfonate moieties were synthesized and characterized by FTIR, H-1-NMR, C-13-NMR spectroscopy and LC-MS spectrometry, besides elemental analysis. The compounds were evaluated for their antiproliferative effects against six cancer cell lines, namely A549 (non-small cell lung cancer), MCF-7 (breast cancer), HT-29 (colorectal adenocarcinoma cancer), PC-3 (androgen-independent prostate adenocarcinoma), Hep3B (hepatocellular carcinoma cancer), and HeLa (epitheloid cervix carcinoma cancer). Among all the target compounds, compounds 4g and 4h exhibited more promising effects on MCF-7 cell lines (IC50 = 17.8 mu M and 21.2 mu M, respectively) with high selectivity. Further mechanistic studies proposed that compounds 4g and 4h induced apoptosis is mediated through the intrinsic apoptotic pathway with changes in mitochondrial membrane potential by finally activating caspase-9 and caspase-3. The results have been encouraging enough to merit further investigation. [GRAPHICS] . en_US
dc.description.sponsorship Scientific and Technological Research Council of Turkey (TUBITAK) [118S840] en_US
dc.description.sponsorship This work was supported financially by the Scientific and Technological Research Council of Turkey (TUBITAK) (Project Number: 118S840). en_US
dc.identifier.citation 25
dc.identifier.doi 10.1007/s00044-021-02837-z
dc.identifier.issn 1054-2523
dc.identifier.issn 1554-8120
dc.identifier.scopus 2-s2.0-85122653861
dc.identifier.uri https://doi.org/10.1007/s00044-021-02837-z
dc.identifier.uri https://hdl.handle.net/20.500.14627/23
dc.language.iso en en_US
dc.publisher Springer Birkhauser en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Hydrazone en_US
dc.subject Sulfonate en_US
dc.subject Anticancer Activity en_US
dc.subject Apoptosis en_US
dc.subject Caspase Activity en_US
dc.title Synthesis and Anticancer Activity of Novel Hydrazone Linkage-Based Aryl Sulfonate Derivatives as Apoptosis Inducers en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id GURBOGA, MERVE/0000-0003-4614-7094
gdc.author.id senkardes, sevil/0000-0002-0523-459X
gdc.author.scopusid 56728813700
gdc.author.scopusid 57196050609
gdc.author.scopusid 57223437357
gdc.author.scopusid 39161700400
gdc.author.scopusid 55894906300
gdc.author.wosid Ozakpinar, Ozlem/ACB-1160-2022
gdc.author.wosid senkardes, sevil/AAA-3948-2020
gdc.author.wosid HAN, MUHAMMED İHSAN/ADF-1623-2022
gdc.author.wosid Küçükgüzel, Ş.Güniz/AAQ-8954-2021
gdc.description.department Fenerbahçe University en_US
gdc.description.departmenttemp [Senkardes, Sevil] Marmara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34854 Istanbul, Turkey; [Han, M. Ihsan] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, TR-38280 Kayseri, Turkey; [Gurboga, Merve; Ozakpinar, Ozlem Bingol] Marmara Univ, Fac Pharm, Dept Biochem, TR-34854 Istanbul, Turkey; [Kucukguzel, S. Guniz] Fenerbahce Univ, Vocat Sch Hlth Serv, TR-34758 Istanbul, Turkey en_US
gdc.description.endpage 379 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 368 en_US
gdc.description.volume 31 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.wos WOS:000741919500001
gdc.scopus.citedcount 29
gdc.wos.citedcount 30
relation.isAuthorOfPublication ccdbdc32-5572-44d5-8ee3-7caed45f6422
relation.isAuthorOfPublication.latestForDiscovery ccdbdc32-5572-44d5-8ee3-7caed45f6422
relation.isOrgUnitOfPublication 5052e089-e75d-4aec-a280-6353973e4819
relation.isOrgUnitOfPublication.latestForDiscovery 5052e089-e75d-4aec-a280-6353973e4819

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-MEDCHEMRES.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format